A Gene Therapy for Hemophilia, Hemgenix, That Costs $3.5 Million Gets FDA Approval

WEDNESDAY, Nov. 23, 2022 -- People with one form of the genetic blood disorder hemophilia now have a one-time treatment with a $3.5 million price tag. The U.S. Food and Drug Administration approved the new gene therapy Hemgenix on Nov. 22. Soon...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news